Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Nov 1;31(21):6365-72.
doi: 10.1093/nar/gkg820.

Expanding the design horizon of antisense oligonucleotides with alpha-L-LNA

Affiliations

Expanding the design horizon of antisense oligonucleotides with alpha-L-LNA

Miriam Frieden et al. Nucleic Acids Res. .

Abstract

Oligonucleotides containing Locked Nucleic Acids (LNA) to various extents and at various positions were evaluated for antisense activity, RNase H recruitment, nuclease stability and thermal affinity. In this work, two different diastereoisomers of LNA were studied: the beta-D-LNA and the alpha-L-LNA (abbreviated as beta-D-LNA and alpha-L-LNA). Our findings show that the best antisense activity with 16mer gapmers containing beta-D-LNA (oligonucleotides containing consecutive segments of LNA and DNA with a central DNA stretch flanked by two LNA segments, LNA-DNA-LNA) is found with gap sizes between 7 and 10 nt. The optimal gap size is motif-dependent, and requires the right balance between gap size and affinity. Compared to beta-D-LNA, alpha-L-LNA shows superior stability against a 3'-exonuclease. The design possibilities of alpha-L-LNA were explored for different gapmers and other designs, collectively called chimeras. The placement of alpha-L-LNA in the junctions or in the flanks resulted in potent antisense oligonucleotides. Moreover, different chimeras with an alternate composition of DNA, alpha-L-LNA and beta-D-LNA were evaluated in terms of antisense activity and RNase H recruitment. Chimeras with an interrupted DNA stretch with alpha-L-LNA still recruit RNase H and show good levels of antisense activity, while the same design with beta-D-LNA results in a drop in antisense potency. Our findings indicate that alpha-L-LNA is a powerful and versatile nucleotide analogue for designing potent antisense oligonucleotides.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chemical structures of β-d-LNA and α-l-LNA.
Figure 2
Figure 2
Down-regulation of Luciferase expression by gapmers (112) with PS in the gap and PO in the flanks containing an increasing gap size from 7 to 10 nt directed against three different motifs (1, 2 and 3) at 2 nM. The melting temperatures (Tm) for the different gapmers are also included in the graph.
Figure 3
Figure 3
Down-regulation of Luciferase expression by fully thiolated oligonucleotides (all PS, 1721) with reduced size and various gap sizes (12 and 14mers) at 2 nM. The 16mer (all PS, 1316) is included as a reference. The melting temperatures (Tm) for the different gapmers are also included in the graph.
Figure 4
Figure 4
Down-regulation of Luciferase expression by oligonucleotides 14 and 15, and the corresponding mismatch-containing control oligonucleotides 35 and 36 directed against motif 3 at 2 nM.
Figure 5
Figure 5
Kinetic study of oligonucleotides containing α-l-LNA at the 3′-end (t10Tαt and t9Tα2t) against a 3′-exonuclease (SVPD), in order to evaluate the nucleolytic stability. The graph also shows the corresponding controls (t12, ts12, t10Tt and t9T2t). The assays were performed using 26 µg/ml oligonucleotide, 0.3 µg/ml enzyme at 37°C in a buffer of 50 mM Tris–HCl, 10 mM MgCl2, pH 8. Aliquots of the enzymatic digestion were removed at the indicated times. In a separate assay, the enzyme was shown to maintain its activity under these conditions for at least 2 h (data not shown). The oligonucleotides were synthesized on deoxynucleoside-support, t. Upper case for LNA and lower case for DNA.
Figure 6
Figure 6
Kinetic study of different oligonucleotide gapmers (16mers) with an increasing deoxynucleotide gap against S1-endonuclease, in order to evaluate the nucleolytic stability. The graph also shows the stability of ts16, T16 and Tα15T against S1-endonuclease. The assay was performed using 1.5 µM oligonucleotide and 16 U/ml enzyme at 37°C in a buffer of 30 mM NaOAc, 100 mM NaCl, 1 mM ZnSO4, pH 4.6. Aliquots of the enzymatic digestion were removed at the indicated times. In a separate assay, the enzyme was shown to maintain its activity under these conditions for at least 2 h (data not shown). Upper case for LNA and lower case for DNA.
Figure 7
Figure 7
Down-regulation of Luciferase expression by different gapmers (9, 2225) and chimeras (2634) containing α-l-LNA and β-d-LNA at 2 and 50 nM. Note: oligonucleotides with and without FAM were tested and compared, and no significant difference was appreciated between the free and FAM-labeled ones.
Figure 8
Figure 8
Electrophoresis analysis of 32P-labeled target RNA degradation products. The chimeras (27, 28, 30, 31 and gapmer 22) containing α-l-LNA and the labeled RNA were incubated with E.coli RNase H1 and aliquots were taken at 0, 10, 20 and 30 min, electrophoresed and reaction products visualized by autoradiography. A gapmer (9) containing β-d-LNA was included in the gel for reference. In the drawing, the line is DNA, the rectangle LNA and the gray shadow corresponds to α-l-LNA residues.

Similar articles

Cited by

References

    1. Zamecnik P.C. and Stephenson,M. (1978) Inhibition of Rous Sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. Proc. Natl Acad. Sci. USA, 75, 280–284. - PMC - PubMed
    1. Uhlmann E. and Peyman,A. (1990) Antisense oligonucleotides: A new therapeutic Principle. Chem. Rev., 90, 543–584.
    1. Crooke S.T. (1999) Molecular mechanisms of action of antisense drugs. Biochim. Biophys. Acta, 1489, 31–44. - PubMed
    1. Woolf T.M., Melton,D.A. and Jennings,C.G.B. (1992) Specificity of antisense oligonucleotides in vivo. Proc. Natl Acad. Sci. USA, 89, 7305–7309. - PMC - PubMed
    1. Cook P.D. (1999) Making drugs out of oligonucleotides: a review and perspective. Nucl. Nucl., 18, 1141–1162. - PubMed

MeSH terms